Elevated expression of S-phase kinase-associated protein-2 (Skp2), a key regulator of S-phase entry, was found to be associated with a worse prognosis in soft tissue sarcomas [3, 4]. This evidence concerns the gene SKP2 and soft tissue sarcoma.